COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
Gold Hunter Completes the Consolidation of Large Gold District
Gold Hunter Resources Inc. completes acquisition of Great Northern and Viking Projects in Newfoundland and Labrador from Magna Terra. Expands mineral claims and acquires Long Range Exploration Corporation. Strategic partnerships with Magna Terra. Appoints new board members -
COMMUNIQUÉ DE PRESSE
Abasca Resources Commences its 2024 Summer Exploration at the KLS Project and Announces Non-Brokered Flow-Through Private Placement of up to $3.65 Million
Abasca Resources Inc. announces 2024 summer exploration program for uranium and graphite projects. Private placement of $3.65 million also disclosed. Details at www.abasca.ca -
COMMUNIQUÉ DE PRESSE
World’s Largest List of Angel Investors Announced, Includes Top 1,000 Angels Adding the Most Value to the Startup Economy
Announcement of the 2024 Arete Index, the world's most comprehensive list of global angel investors, revealed at the Founders Angels Forum in London by Oskar Hartmann, Founders Forum Group, and the Accumulator Angel Fund -
COMMUNIQUÉ RÉGLEMENTÉ
EURAZEO INVESTIT DANS COGNIGY, UN LEADER MONDIAL DES SOLUTIONS DE SERVICE CLIENT PILOTEES PAR L’INTELLIGENCE ARTIFICIELLE
Eurazeo investit 50 millions d'euros dans Cognigy, leader mondial des services clients pilotés par l'IA, pour financer la Série C et accélérer son expansion internationale -
-
COMMUNIQUÉ DE PRESSE
Northern Superior Announces the Appointment of Eric Desaulniers to Its Board of Directors
Northern Superior Resources Inc. appoints Eric Desaulniers as Director, signaling readiness for development phase in Chibougamau Gold Camp. Desaulniers brings extensive experience in mineral exploration and leadership -
COMMUNIQUÉ DE PRESSE
Tacalyx Extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs
Tacalyx extends seed round to over €14 M led by Thuja Capital to advance development of cancer therapeutics targeting TACAs, aiming to create novel treatment options for patients with specificity across solid tumor indications -
